Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/15/2003EP1352910A1 New analogs of nitrobenzylthioinosine
10/15/2003EP1352907A1 Processes for preparing calanolide a and intermediates thereof
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352659A1 Combination drugs
10/15/2003EP1352657A1 Interferon therapeutic effect-potentiating agents
10/15/2003EP1352655A1 Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents
10/15/2003EP1352653A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy
10/15/2003EP1352652A1 Fat composition for oral or enteral administration and hexacosanoic acid depressant
10/15/2003EP1352640A1 Compositions for retarding skin aging
10/15/2003EP1352092A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/15/2003EP1352084A2 Method for identifying modulators of bace
10/15/2003EP1352073A2 Electrically responsive promoter system
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1352053A2 Method for processing dendritic cells and for activating macrophages with ru 41740
10/15/2003EP1351986A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
10/15/2003EP1351979A1 Regulated activation of cell-membrane receptors by metal-chelating agonists
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351966A1 Improved specificity in treatment of diseases
10/15/2003EP1351962A2 Thienopyrimidine
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351957A1 Chemical derivatives and their use as anti-telomerase agent
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351955A1 Excitatory amino acid receptor antagonists
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351935A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351932A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
10/15/2003EP1351930A2 Protease inhibitors
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351742A2 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
10/15/2003EP1351709A2 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
10/15/2003EP1351702A1 Trem-1 splice variant for use in modifying immune responses
10/15/2003EP1351701A2 Active metabolite of antifungal compound
10/15/2003EP1351694A1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
10/15/2003EP1351693A1 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
10/15/2003EP1351690A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
10/15/2003EP1351688A1 Urotensin-ii receptor antagonists
10/15/2003EP1351686A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/15/2003EP1351682A1 Regulation of lipids and/or bone density and compositions therefor
10/15/2003EP1351681A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/15/2003EP1351679A2 Method and composition for the treatment of diabetic neuropathy
10/15/2003EP1351677A2 Method for treating cancer
10/15/2003EP1351675A2 Alpha-difluoromethylornithine (dfmo) use in the human prostate
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1351671A1 Triphenylmethane kinesin inhibitors
10/15/2003EP1351670A1 Methods for treating neuropsychiatric disorders with nmda receptor antagonists
10/15/2003EP1351663A1 Cosmetic and/or pharmaceutical preparations
10/15/2003EP1351662A1 Cosmetic and/or pharmaceutical preparations
10/15/2003EP1351648A2 Carrier vectors through an epithelium with tight junctions
10/15/2003EP1351573A1 Methods for modulating tumor growth and metastasis
10/15/2003EP1265873B1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1228041B1 Indole derivatives and their use as 5ht2a ligands
10/15/2003EP1212316B1 Benzopyrans and benzothiopyrans as rar selective retinoid agonists
10/15/2003EP1206457B1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
10/15/2003EP1173181B1 Composition comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction
10/15/2003EP1135103B1 Use of plant extracts with an anti-radical-type action and cosmetic or dermopharmaceutical composition comprising such extracts
10/15/2003EP1054890B1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
10/15/2003EP1005332B1 Pharmaceutical composition for reducing production of mcp-1 protein
10/15/2003EP0975370B1 Composition and method for enhancing transport across biological membranes
10/15/2003EP0972768B1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same
10/15/2003EP0956019B1 Novel therapeutic application of a thienycyclohexylamine derivative
10/15/2003EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/15/2003EP0888351B1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003EP0797575B1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/15/2003EP0766674B1 New hiv protease inhibitors
10/15/2003EP0763032B1 Palladium catalyzed ring closure of triazolyl tryptamine
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003CN1449493A Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1449396A Carbamates derived from arylalkylamines
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1449294A Parenteral vaccine formulations and uses thereof
10/15/2003CN1449288A Pharmaceutical formulation of salmeterol and fluticasone propionate
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1449286A Carvedilol
10/15/2003CN1449285A Use of il-8 receptor antagonists in the treatment of virus infections
10/15/2003CN1449278A Lung surfactant compositions with dynamic swelling behaviour
10/15/2003CN1449273A Antimicotic nail varnish composition
10/15/2003CN1448505A Method for production of phytolaccatoxin medicinal active substance
10/15/2003CN1448150A Plaster for curing self-sweating and night sweat
10/15/2003CN1124276C Rapamycin derivatives
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 1564